Tower Research Capital LLC (Trc) Protara Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 117 shares of TARA stock, worth $435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117
Previous 2,783
95.8%
Holding current value
$435
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
29.8MCall Options Held
49.5KPut Options Held
181K-
Ra Capital Management, L.P. Boston, MA3.4MShares$12.6 Million0.29% of portfolio
-
Janus Henderson Group PLC London, X02.27MShares$8.45 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.25MShares$8.37 Million0.02% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A62.09MShares$7.77 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA1.83MShares$6.79 Million1.88% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $41.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...